Business Description
Professional Medical Expertise Co
SIC : 5047
ISIN : SA15RH24LJ13
Description
Professional Medical Expertise Co, listed on the Saudi Exchange under ticker 9574, distributes medical devices and related products in Saudi Arabia. The company imports, exports, and sells medical implants, devices, and consumables to hospitals, medical centers, and other healthcare providers. It also acts as a sales agent for pharmaceutical products, operates retail sales of medical equipment and supplies, and provides warehousing and storage services for medical and pharmaceutical goods. In addition, it represents medical device manufacturers in regulatory and legal matters. Revenue is generated primarily through distribution margins and agency commissions, supported by logistics and storage services. Its customer base consists mainly of healthcare institutions and medical professionals across Saudi Arabia.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | 1.8 | |||||
Interest Coverage | 116.12 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.79 | |||||
Beneish M-Score | -1.89 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.5 | |||||
3-Year EBITDA Growth Rate | 24.4 | |||||
3-Year EPS without NRI Growth Rate | 29.1 | |||||
3-Year FCF Growth Rate | -31.1 | |||||
3-Year Book Growth Rate | 27.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.7 | |||||
9-Day RSI | 35.26 | |||||
14-Day RSI | 39.91 | |||||
3-1 Month Momentum % | 1.63 | |||||
6-1 Month Momentum % | -10.22 | |||||
12-1 Month Momentum % | 0.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 222.71 | |||||
Days Sales Outstanding | 182.32 | |||||
Days Payable | 169.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -4.33 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.92 | |||||
Operating Margin % | 14.42 | |||||
Net Margin % | 9.95 | |||||
EBITDA Margin % | 13.27 | |||||
FCF Margin % | 0.83 | |||||
OCF Margin % | 4.63 | |||||
ROE % | 28.86 | |||||
ROA % | 10.36 | |||||
ROIC % | 19.51 | |||||
3-Year ROIIC % | 19.32 | |||||
ROC (Joel Greenblatt) % | 18.58 | |||||
ROCE % | 28.61 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.57 | |||||
PE Ratio without NRI | 6.57 | |||||
PS Ratio | 0.66 | |||||
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 1.67 | |||||
Price-to-Free-Cash-Flow | 21.08 | |||||
Price-to-Operating-Cash-Flow | 8.89 | |||||
EV-to-EBIT | 7.93 | |||||
EV-to-EBITDA | 6.58 | |||||
EV-to-Revenue | 0.88 | |||||
EV-to-FCF | 29.29 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Graham-Number | 0.7 | |||||
| Price-to-Net-Current-Asset-Value | 1.98 | |||||
Earnings Yield (Greenblatt) % | 12.6 | |||||
FCF Yield % | 4.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Professional Medical Expertise Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 441.449 | ||
| EPS (TTM) (ï·¼) | 12.548 | ||
| Beta | 0.2364 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.45 | ||
| Volatility % | 23.82 | ||
| 14-Day RSI | 39.91 | ||
| 14-Day ATR (ï·¼) | 9.654805 | ||
| 20-Day SMA (ï·¼) | 86.17 | ||
| 12-1 Month Momentum % | 0.34 | ||
| 52-Week Range (ï·¼) | 77.8 - 107 | ||
| Shares Outstanding (Mil) | 3.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Professional Medical Expertise Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Professional Medical Expertise Co Stock Events
| Event | Date | Price (ï·¼) | ||
|---|---|---|---|---|
| SAR 1.000000 Cash Dividend | 2025-06-25 | 86.00 (-0.58%) |
Show
Entries
Professional Medical Expertise Co Frequently Asked Questions
What is Professional Medical Expertise Co(SAU:9574)'s stock price today?
The current price of SAU:9574 is ï·¼82.00. The 52 week high of SAU:9574 is ï·¼107.00 and 52 week low is ï·¼77.80.
When is next earnings date of Professional Medical Expertise Co(SAU:9574)?
The next earnings date of Professional Medical Expertise Co(SAU:9574) is .
Does Professional Medical Expertise Co(SAU:9574) pay dividends? If so, how much?
Professional Medical Expertise Co(SAU:9574) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||